Works by Di Gennaro, Elena


Results: 40
    1
    2
    3
    4
    5
    6
    7

    A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

    Published in:
    2015
    By:
    • Avallone, Antonio;
    • Piccirillo, Maria Carmela;
    • Aloj, Luigi;
    • Nasti, Guglielmo;
    • Delrio, Paolo;
    • Izzo, Francesco;
    • Di Gennaro, Elena;
    • Tatangelo, Fabiana;
    • Granata, Vincenza;
    • Cavalcanti, Ernesta;
    • Maiolino, Piera;
    • Bianco, Francesco;
    • Aprea, Pasquale;
    • De Bellis, Mario;
    • Pecori, Biagio;
    • Rosati, Gerardo;
    • Carlomagno, Chiara;
    • Bertolini, Alessandro;
    • Gallo, Ciro;
    • Romano, Carmela
    Publication type:
    journal article
    8

    Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial).

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-875
    By:
    • Avallone, Antonio;
    • Piccirillo, Maria Carmela;
    • Delrio, Paolo;
    • Pecori, Biagio;
    • Di Gennaro, Elena;
    • Aloj, Luigi;
    • Tatangelo, Fabiana;
    • D¿Angelo, Valentina;
    • Granata, Cinzia;
    • Cavalcanti, Ernesta;
    • Maurea, Nicola;
    • Maiolino, Piera;
    • Bianco, Franco;
    • Montano, Massimo;
    • Silvestro, Lucrezia;
    • Terranova Barberio, Manuela;
    • Serena Roca, Maria;
    • Di Maio, Massimo;
    • Marone, Pietro;
    • Botti, Gerardo
    Publication type:
    Article
    9

    Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial).

    Published in:
    BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-875
    By:
    • Avallone, Antonio;
    • Piccirillo, Maria Carmela;
    • Delrio, Paolo;
    • Pecori, Biagio;
    • Di Gennaro, Elena;
    • Aloj, Luigi;
    • Tatangelo, Fabiana;
    • D'Angelo, Valentina;
    • Granata, Cinzia;
    • Cavalcanti, Ernesta;
    • Maurea, Nicola;
    • Maiolino, Piera;
    • Bianco, Franco;
    • Montano, Massimo;
    • Silvestro, Lucrezia;
    • Barberio, Manuela Terranova;
    • Roca, Maria Serena;
    • Di Maio, Massimo;
    • Marone, Pietro;
    • Botti, Gerardo
    Publication type:
    Article
    10

    Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).

    Published in:
    2014
    By:
    • Avallone, Antonio;
    • Piccirillo, Maria Carmela;
    • Delrio, Paolo;
    • Pecori, Biagio;
    • Di Gennaro, Elena;
    • Aloj, Luigi;
    • Tatangelo, Fabiana;
    • D'Angelo, Valentina;
    • Granata, Cinzia;
    • Cavalcanti, Ernesta;
    • Maurea, Nicola;
    • Maiolino, Piera;
    • Bianco, Franco;
    • Montano, Massimo;
    • Silvestro, Lucrezia;
    • Terranova Barberio, Manuela;
    • Roca, Maria Serena;
    • Di Maio, Massimo;
    • Marone, Pietro;
    • Botti, Gerardo
    Publication type:
    journal article
    11

    Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2021, v. 4, n. 7, p. e2118475, doi. 10.1001/jamanetworkopen.2021.18475
    By:
    • Avallone, Antonio;
    • Piccirillo, Maria C.;
    • Nasti, Guglielmo;
    • Rosati, Gerardo;
    • Carlomagno, Chiara;
    • Di Gennaro, Elena;
    • Romano, Carmela;
    • Tatangelo, Fabiana;
    • Granata, Vincenza;
    • Cassata, Antonino;
    • Silvestro, Lucrezia;
    • De Stefano, Alfonso;
    • Aloj, Luigi;
    • Vicario, Valeria;
    • Nappi, Anna;
    • Leone, Alessandra;
    • Bilancia, Domenico;
    • Arenare, Laura;
    • Petrillo, Antonella;
    • Lastoria, Secondo
    Publication type:
    Article
    12

    Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.

    Published in:
    BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2957-y
    By:
    • Caponigro, Francesco;
    • Di Gennaro, Elena;
    • Ionna, Franco;
    • Longo, Francesco;
    • Aversa, Corrado;
    • Pavone, Ettore;
    • Maglione, Maria Grazia;
    • Di Marzo, Massimiliano;
    • Muto, Paolo;
    • Cavalcanti, Ernesta;
    • Petrillo, Antonella;
    • Sandomenico, Fabio;
    • Maiolino, Piera;
    • D'Aniello, Roberta;
    • Botti, Gerardo;
    • De Cecio, Rossella;
    • Losito, Nunzia Simona;
    • Scala, Stefania;
    • Trotta, Annamaria;
    • Zott, Andrea Ilaria
    Publication type:
    Article
    13

    A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

    Published in:
    BMC Cancer, 2016, v. 16, p. 1
    By:
    • Avallone, Antonio;
    • Piccirillo, Maria Carmela;
    • Aloj, Luigi;
    • Nasti, Guglielmo;
    • Delrio, Paolo;
    • Izzo, Francesco;
    • Di Gennaro, Elena;
    • Tatangelo, Fabiana;
    • Granata, Vincenza;
    • Cavalcanti, Ernesta;
    • Maiolino, Piera;
    • Bianco, Francesco;
    • Aprea, Pasquale;
    • De Bellis, Mario;
    • Pecori, Biagio;
    • Rosati, Gerardo;
    • Carlomagno, Chiara;
    • Bertolini, Alessandro;
    • Gallo, Ciro;
    • Romano, Carmela
    Publication type:
    Article
    14

    Paper-based electrochemical device for early detection of integrin αvβ6 expressing tumors.

    Published in:
    Communications Chemistry, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42004-024-01144-z
    By:
    • Cinti, Stefano;
    • Tomassi, Stefano;
    • Ciardiello, Chiara;
    • Migliorino, Rossella;
    • Pirozzi, Marinella;
    • Leone, Alessandra;
    • Di Gennaro, Elena;
    • Campani, Virginia;
    • De Rosa, Giuseppe;
    • D'Amore, Vincenzo Maria;
    • Di Maro, Salvatore;
    • Donati, Greta;
    • Singh, Sima;
    • Raucci, Ada;
    • Di Leva, Francesco Saverio;
    • Kessler, Horst;
    • Budillon, Alfredo;
    • Marinelli, Luciana
    Publication type:
    Article
    15

    Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. N.PAG, doi. 10.1186/s13046-020-01723-7
    By:
    • Iannelli, Federica;
    • Roca, Maria Serena;
    • Lombardi, Rita;
    • Ciardiello, Chiara;
    • Grumetti, Laura;
    • De Rienzo, Simona;
    • Moccia, Tania;
    • Vitagliano, Carlo;
    • Sorice, Angela;
    • Costantini, Susan;
    • Milone, Maria Rita;
    • Pucci, Biagio;
    • Leone, Alessandra;
    • Di Gennaro, Elena;
    • Mancini, Rita;
    • Ciliberto, Gennaro;
    • Bruzzese, Francesca;
    • Budillon, Alfredo
    Publication type:
    Article
    16

    Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1317-6
    By:
    • Ciardiello, Chiara;
    • Leone, Alessandra;
    • Lanuti, Paola;
    • Roca, Maria S.;
    • Moccia, Tania;
    • Minciacchi, Valentina R.;
    • Minopoli, Michele;
    • Gigantino, Vincenzo;
    • De Cecio, Rossella;
    • Rippa, Massimo;
    • Petti, Lucia;
    • Capone, Francesca;
    • Vitagliano, Carlo;
    • Milone, Maria R.;
    • Pucci, Biagio;
    • Lombardi, Rita;
    • Iannelli, Federica;
    • Di Gennaro, Elena;
    • Bruzzese, Francesca;
    • Marchisio, Marco
    Publication type:
    Article
    17
    18

    HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02295-4
    By:
    • Roca, Maria Serena;
    • Moccia, Tania;
    • Iannelli, Federica;
    • Testa, Cristina;
    • Vitagliano, Carlo;
    • Minopoli, Michele;
    • Camerlingo, Rosa;
    • De Riso, Giulia;
    • De Cecio, Rossella;
    • Bruzzese, Francesca;
    • Conte, Mariarosaria;
    • Altucci, Lucia;
    • Di Gennaro, Elena;
    • Avallone, Antonio;
    • Leone, Alessandra;
    • Budillon, Alfredo
    Publication type:
    Article
    19
    20

    HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02295-4
    By:
    • Roca, Maria Serena;
    • Moccia, Tania;
    • Iannelli, Federica;
    • Testa, Cristina;
    • Vitagliano, Carlo;
    • Minopoli, Michele;
    • Camerlingo, Rosa;
    • De Riso, Giulia;
    • De Cecio, Rossella;
    • Bruzzese, Francesca;
    • Conte, Mariarosaria;
    • Altucci, Lucia;
    • Di Gennaro, Elena;
    • Avallone, Antonio;
    • Leone, Alessandra;
    • Budillon, Alfredo
    Publication type:
    Article
    21

    HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02295-4
    By:
    • Roca, Maria Serena;
    • Moccia, Tania;
    • Iannelli, Federica;
    • Testa, Cristina;
    • Vitagliano, Carlo;
    • Minopoli, Michele;
    • Camerlingo, Rosa;
    • De Riso, Giulia;
    • De Cecio, Rossella;
    • Bruzzese, Francesca;
    • Conte, Mariarosaria;
    • Altucci, Lucia;
    • Di Gennaro, Elena;
    • Avallone, Antonio;
    • Leone, Alessandra;
    • Budillon, Alfredo
    Publication type:
    Article
    22
    23
    24

    Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2025, v. 44, n. 1, p. 1, doi. 10.1186/s13046-025-03378-8
    By:
    • Costantini, Susan;
    • Madonna, Gabriele;
    • Capone, Mariaelena;
    • Di Gennaro, Elena;
    • Bagnara, Palmina;
    • Renza, Federica;
    • Mallardo, Domenico;
    • Affatato, Roberta;
    • Vitagliano, Carlo;
    • Romanelli, Marilena;
    • Tuffanelli, Marilena;
    • Simeone, Ester;
    • Ciliberto, Gennaro;
    • Ascierto, Paolo A.;
    • Budillon, Alfredo
    Publication type:
    Article
    25

    The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promising circulating biomarkers.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03117-5
    By:
    • Mottini, Carla;
    • Auciello, Francesca Romana;
    • Manni, Isabella;
    • Pilarsky, Christian;
    • Caputo, Damiano;
    • Caracciolo, Giulio;
    • Rossetta, Alessandro;
    • Di Gennaro, Elena;
    • Budillon, Alfredo;
    • Blandino, Giovanni;
    • Roca, Maria Serena;
    • Piaggio, Giulia
    Publication type:
    Article
    26
    27

    Caveolin-1 overexpression is associated with simultaneous abnormal expression of the E-cadherin/α-β catenins complex and multiple erbb receptors and with lymph nodes metastasis in head and neck squamous cell carcinomas.

    Published in:
    Journal of Cellular Physiology, 2012, v. 227, n. 9, p. 3344, doi. 10.1002/jcp.24034
    By:
    • Masuelli, Laura;
    • Budillon, Alfredo;
    • Marzocchella, Laura;
    • Mrozek, Marie-Agnes;
    • Vitolo, Domenico;
    • Di Gennaro, Elena;
    • Losito, Simona;
    • Sale, Patrizio;
    • Longo, Francesco;
    • Ionna, Franco;
    • Lista, Florigio;
    • Muraro, Raffaella;
    • Modesti, Andrea;
    • Bei, Roberto
    Publication type:
    Article
    28
    29

    Critical role of both p27<sup>KIP1</sup>and p21<sup>CIP1/WAF1</sup> in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells (‘Iressa’ is a trademark of the AstraZeneca group of companies.)

    Published in:
    Journal of Cellular Physiology, 2003, v. 195, n. 1, p. 139, doi. 10.1002/jcp.10239
    By:
    • Elena Di Gennaro;
    • Marcella Barbarino;
    • Francesca Bruzzese;
    • Sonya De Lorenzo;
    • Michele Caraglia;
    • Alberto Abbruzzese;
    • Antonio Avallone;
    • Pasquale Comella;
    • Francesco Caponigro;
    • Stefano Pepe
    Publication type:
    Article
    30

    Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol.

    Published in:
    BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12936-w
    By:
    • Budillon, Alfredo;
    • Leone, Alessandra;
    • Passaro, Eugenia;
    • Silvestro, Lucrezia;
    • Foschini, Francesca;
    • Iannelli, Federica;
    • Roca, Maria Serena;
    • Macchini, Marina;
    • Bruzzese, Francesca;
    • Garcia Bermejo, Maria Laura;
    • Rodriguez Garrote, Mercedes;
    • Tortora, Giampaolo;
    • Milella, Michele;
    • Reni, Michele;
    • Fuchs, Claudia;
    • Hewitt, Eve;
    • Kubiak, Christine;
    • Di Gennaro, Elena;
    • Giannarelli, Diana;
    • Avallone, Antonio
    Publication type:
    Article
    31
    32

    Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS -mutated metastatic colorectal cancer: the REVOLUTION study protocol.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920929589
    By:
    • Avallone, Antonio;
    • Piccirillo, Maria Carmela;
    • Di Gennaro, Elena;
    • Romano, Carmela;
    • Calabrese, Filomena;
    • Roca, Maria Serena;
    • Tatangelo, Fabiana;
    • Granata, Vincenza;
    • Cassata, Antonio;
    • Cavalcanti, Ernesta;
    • Maurea, Nicola;
    • Maiolino, Piera;
    • Silvestro, Lucrezia;
    • De Stefano, Alfonso;
    • Giuliani, Francesco;
    • Rosati, Gerardo;
    • Tamburini, Emiliano;
    • Aprea, Pasquale;
    • Vicario, Valeria;
    • Nappi, Anna
    Publication type:
    Article
    33

    Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS -mutated metastatic colorectal cancer: the REVOLUTION study protocol.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920929589
    By:
    • Avallone, Antonio;
    • Piccirillo, Maria Carmela;
    • Di Gennaro, Elena;
    • Romano, Carmela;
    • Calabrese, Filomena;
    • Roca, Maria Serena;
    • Tatangelo, Fabiana;
    • Granata, Vincenza;
    • Cassata, Antonio;
    • Cavalcanti, Ernesta;
    • Maurea, Nicola;
    • Maiolino, Piera;
    • Silvestro, Lucrezia;
    • De Stefano, Alfonso;
    • Giuliani, Francesco;
    • Rosati, Gerardo;
    • Tamburini, Emiliano;
    • Aprea, Pasquale;
    • Vicario, Valeria;
    • Nappi, Anna
    Publication type:
    Article
    34
    35
    36

    New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer.

    Published in:
    International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4922, doi. 10.3390/ijms24054922
    By:
    • Costantini, Susan;
    • Madonna, Gabriele;
    • Di Gennaro, Elena;
    • Capone, Francesca;
    • Bagnara, Palmina;
    • Capone, Mariaelena;
    • Sale, Silvia;
    • Nicastro, Carmine;
    • Atripaldi, Lidia;
    • Fiorentino, Giuseppe;
    • Parrella, Roberto;
    • Montesarchio, Vincenzo;
    • Atripaldi, Luigi;
    • Ascierto, Paolo A.;
    • Budillon, Alfredo
    Publication type:
    Article
    37
    38

    Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood.

    Published in:
    Cytometry. Part A, 2016, v. 89, n. 3, p. 259, doi. 10.1002/cyto.a.22730
    By:
    • Lanuti, Paola;
    • Rotta, Gianluca;
    • Almici, Camillo;
    • Avvisati, Giuseppe;
    • Budillon, Alfredo;
    • Doretto, Paolo;
    • Malara, Natalia;
    • Marini, Mirella;
    • Neva, Arabella;
    • Simeone, Pasquale;
    • Di Gennaro, Elena;
    • Leone, Alessandra;
    • Falda, Alessandra;
    • Tozzoli, Renato;
    • Gregorj, Chiara;
    • Di Cerbo, Melania;
    • Trunzo, Valentina;
    • Mollace, Vincenzo;
    • Marchisio, Marco;
    • Miscia, Sebastiano
    Publication type:
    Article
    39
    40

    Integrated proteomics and metabolomics analyses reveal new insights into the antitumor effects of valproic acid plus simvastatin combination in a prostate cancer xenograft model associated with downmodulation of YAP/TAZ signaling.

    Published in:
    Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03573-1
    By:
    • Iannelli, Federica;
    • Lombardi, Rita;
    • Costantini, Susan;
    • Roca, Maria Serena;
    • Addi, Laura;
    • Bruzzese, Francesca;
    • Di Gennaro, Elena;
    • Budillon, Alfredo;
    • Pucci, Biagio
    Publication type:
    Article